Mallinckrodt Announces Publication of Human Factors Studies and Arthritis Foundation Ease of Use® Certification of Acthar® Gel (repository corticotropin injection) Single-Dose Pre-filled...
THERAKOS™ CELLEX™ Photopheresis System Receives CE Certificate Under the European Union Medical Device Regulation (EU MDR) PR Newswire DUBLIN, Sept. 3, 2024 – THERAKOS, the world's only fully...
Mallinckrodt plc Reports Second Quarter 2024 Financial Results and Raises Full Year Guidance PR Newswire DUBLIN, Aug. 6, 2024 Achieves Second Quarter Net Sales of $514.3 Million, Reflecting...
Mallinckrodt Announces Availability of Acthar® Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect™ Injector in the U.S. PR Newswire DUBLIN, Aug. 6, 2024 – Acthar Gel is the...
Mallinckrodt Reaches Agreement to Sell Therakos® Business to CVC for $925 Million PR Newswire DUBLIN and LUXEMBOURG, Aug. 5, 2024 Divestiture Advances Mallinckrodt's Strategic Priorities to...
Mallinckrodt to Report Earnings Results for Second Quarter 2024 PR Newswire DUBLIN, Aug. 1, 2024 DUBLIN, Aug. 1, 2024 /PRNewswire/ -- Mallinckrodt plc ("Mallinckrodt" or the "Company"), a global...
US Index Futures are marginally lower in Tuesday’s premarket, awaiting important economic data, which may define the trajectory of interest rates around the world. By 6:51 AM, Dow Jones...
Mallinckrodt plc Takes Next Step to Implement Comprehensive Financial Restructuring Plan to Address Long-Term Debt and Opioid Obligations PR Newswire DUBLIN, Aug. 28, 2023 Initiates Voluntary...
Mallinckrodt plc Takes Next Step to Implement Comprehensive Financial Restructuring Plan to Address Long-Term Debt and Opioid Obligations PR Newswire DUBLIN, Aug. 28, 2023 Initiates Voluntary...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.3402 | 0.3402 | 0.3402 | 0 | 0 | CS |
4 | 0 | 0 | 0.3402 | 0.3402 | 0.3402 | 0 | 0 | CS |
12 | 0 | 0 | 0.3402 | 0.3402 | 0.3402 | 0 | 0 | CS |
26 | 0 | 0 | 0.3402 | 0.3402 | 0.3402 | 0 | 0 | CS |
52 | 0 | 0 | 0.3402 | 0.3402 | 0.3402 | 0 | 0 | CS |
156 | -15.2498 | -97.8178319436 | 15.59 | 16.44 | 0.3 | 680630 | 2.81191598 | CS |
260 | -15.2498 | -97.8178319436 | 15.59 | 16.44 | 0.3 | 680630 | 2.81191598 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.